Polar Capital Holdings’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.6M | Buy |
2,517,779
+267,779
| +12% | +$4.85M | 0.24% | 95 |
|
|
2025
Q1 | $46.1M | Buy |
2,250,000
+500,000
| +29% | +$10.2M | 0.28% | 100 |
|
|
2024
Q4 | $45M | Buy |
1,750,000
+245,000
| +16% | +$6.3M | 0.25% | 99 |
|
|
2024
Q3 | $25M | Buy |
1,505,000
+502,414
| +50% | +$8.34M | 0.12% | 124 |
|
|
2024
Q2 | $19.3M | Sell |
1,002,586
-250,000
| -20% | -$4.8M | 0.11% | 138 |
|
|
2024
Q1 | $29.6M | Buy |
+1,252,586
| New | +$29.6M | 0.16% | 119 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 296 |
|